Research Insight

The biopharmaceutical industry in the Asia-Pacific area has seen a significant strategic shift in recent years; this trend is now commonly acknowledged as Asia's bio sovereignty movement. Countries like China, India, Japan, South Korea, and Singapore are making daring...

The struggle to get new medications onto the market is more intense than ever in the rapidly evolving pharmaceutical industry of today. Separated into sequential segments, the traditional drug development process can be costly and time-consuming. Converging drug material...

The pharmaceutical manufacturing spectrum is going through a profound shift with contract development manufacturing organizations (CDMOs) transitioning from just being simple capacity providers to becoming strategic partners. This shift comes as pharmaceutical companies face very intense pressure in order to...

Artificial intelligence has rapidly evolved from academic theory into a transformative force in pharmaceutical R&D. From early QSAR models to neural networks, and now to AlphaFold3, AI has progressively unlocked deeper biological insights. By integrating structure prediction, molecular modeling,...

The biopharmaceutical sector, although being a pioneer when it comes to advancing healthcare, is also growing under scrutiny in terms of its environmental footprint. Fluid handling in biopharma, which happen to be the epicentre when it comes to biomanufacturing processes,...

As the biologic therapies go on to become increasingly sophisticated, many of the newest formulations, especially the ones in monoclonal antibodies (mAbs), gene therapy, and fusion proteins, are inherently high when it comes to viscosity. These high-viscosity biologics go on...

The growth when it comes to single-use technologies has gone on to redefine modern biomanufacturing. Once regarded as a very niche choice, single-use assemblies (SUAs) have gone on to become an integral part of upstream and downstream as well...